Mario Boccadoro
Mario Boccadoro
Emeritus Professor of Hematology, University of Torino, Italy
Verified email at
Cited by
Cited by
International staging system for multiple myeloma
PR Greipp, JS Miguel, BGM Durie, JJ Crowley, B Barlogie, J Bladé, ...
Journal of clinical oncology 23 (15), 3412-3420, 2005
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson, P Sonneveld, MW Schuster, D Irwin, EA Stadtmauer, ...
New England journal of medicine 352 (24), 2487-2498, 2005
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
International Myeloma Working Group
British journal of haematology 121 (5), 749-757, 2003
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ...
The Lancet 367 (9513), 825-831, 2006
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hájek, ...
Leukemia 23 (2), 215-224, 2009
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ...
Leukemia 22 (2), 414-423, 2008
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and …
RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ...
Leukemia 24 (6), 1121-1127, 2010
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
Autologous transplantation and maintenance therapy in multiple myeloma
A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ...
New England Journal of Medicine 371 (10), 895-905, 2014
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
F Pichiorri, SS Suh, M Ladetto, M Kuehl, T Palumbo, D Drandi, C Taccioli, ...
Proceedings of the National Academy of Sciences 105 (35), 12885-12890, 2008
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial
PG Richardson, P Sonneveld, M Schuster, D Irwin, E Stadtmauer, T Facon, ...
Blood, The Journal of the American Society of Hematology 110 (10), 3557-3560, 2007
A comparison of allografting with autografting for newly diagnosed myeloma
B Bruno, M Rotta, F Patriarca, N Mordini, B Allione, F Carnevale-Schianca, ...
New England Journal of Medicine 356 (11), 1110-1120, 2007
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
BGM Durie, RA Kyle, A Belch, W Bensinger, J Blade, M Boccadoro, ...
The Hematology Journal 4 (6), 379-398, 2003
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
MA Dimopoulos, P Moreau, E Terpos, MV Mateos, S Zweegman, G Cook, ...
Hemasphere 5 (2), e528, 2021
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
M Dimopoulos, R Kyle, JP Fermand, SV Rajkumar, J San Miguel, ...
Blood, The Journal of the American Society of Hematology 117 (18), 4701-4705, 2011
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple …
A Palumbo, S Bringhen, D Rossi, M Cavalli, A Larocca, R Ria, M Offidani, ...
Journal of Clinical Oncology 28 (34), 5101-5109, 2010
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
S Bringhen, A Larocca, D Rossi, M Cavalli, M Genuardi, R Ria, S Gentili, ...
Blood, The Journal of the American Society of Hematology 116 (23), 4745-4753, 2010
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
A Palumbo, S Bringhen, H Ludwig, MA Dimopoulos, J Bladé, MV Mateos, ...
Blood, The Journal of the American Society of Hematology 118 (17), 4519-4529, 2011
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
A Palumbo, S Bringhen, AM Liberati, T Caravita, A Falcone, V Callea, ...
Blood, The Journal of the American Society of Hematology 112 (8), 3107-3114, 2008
The system can't perform the operation now. Try again later.
Articles 1–20